Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of postoperative low cardiac output syndrome in neonates undergoing cardiovascular surgery
2009-010404-28Phase 2Active
- Sponsor
- Fundación de Investigación Biomédica del Hospital Universitario La Paz
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of milrinone and levosimendan in low cardiac output syndrome (LCOS) (2 arms), sponsored by Fundación de Investigación Biomédica del Hospital Universitario La Paz. Primary endpoints: Hemodynamic and respiratory indicators, Dose-dependent pharmacokinetics of inodilators and 2 more. Started Mar 2009; status: active.
02
Drugs
milrinonelevosimendan
03
Conditions
low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on 2009-010404-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010404-28.